Last Updated: November 8, 2026

READYPREP CHG Drug Patent Profile

« Back to Dashboard


Which patents cover Readyprep Chg, and when can generic versions of Readyprep Chg launch?

Readyprep Chg is a drug marketed by Medline Industries and is included in one NDA.

The generic ingredient in READYPREP CHG is chlorhexidine gluconate. There is one drug master file entry for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Readyprep Chg

A generic version of READYPREP CHG was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for READYPREP CHG?
  • What are the global sales for READYPREP CHG?
  • What is Average Wholesale Price for READYPREP CHG?
Summary for READYPREP CHG
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 42
Clinical Trials: 1
What excipients (inactive ingredients) are in READYPREP CHG?READYPREP CHG excipients list
DailyMed Link:READYPREP CHG at DailyMed
Recent Clinical Trials for READYPREP CHG

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medline IndustriesPhase 1

See all READYPREP CHG clinical trials

Pharmacology for READYPREP CHG
Physiological EffectDecreased Cell Wall Integrity

US Patents and Regulatory Information for READYPREP CHG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medline Industries READYPREP CHG chlorhexidine gluconate CLOTH;TOPICAL 207964-001 Nov 20, 2018 OTC Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.